THYROID GLAND PAPILLARY CARCINOMA
Clinical trials for THYROID GLAND PAPILLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND PAPILLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shrinks thyroid tumors before surgery in early trial
Disease control OngoingThis phase 2 trial tests the drug selpercatinib given before surgery in 30 people with thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if the drug can shrink tumors and make surgery more successful. Participants take selpercatinib for a shor…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New drug cocktail shows promise for Hard-to-Treat thyroid cancer
Disease control OngoingThis study tests a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) in people with a type of thyroid cancer that no longer responds to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this mix can shrink or control th…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC